Research
Benzodiazepine use and risk of dementia: prospective population based study
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e6231 (Published 27 September 2012) Cite this as: BMJ 2012;345:e6231Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
Related articles
- PAPERS Published: 11 November 2005; BMJ doi:10.1136/bmj.38623.768588.47
- Paper Published: 17 November 2005; BMJ 331 doi:10.1136/bmj.38623.768588.47
- Paper Published: 24 March 2001; BMJ 322 doi:10.1136/bmj.322.7288.704
- Letter Published: 26 November 2012; BMJ 345 doi:10.1136/bmj.e7984
- Letter Published: 26 November 2012; BMJ 345 doi:10.1136/bmj.e7986
- Letter Published: 26 November 2012; BMJ 345 doi:10.1136/bmj.e7993
- Research Published: 19 March 2014; BMJ 348 doi:10.1136/bmj.g1996
- Research Published: 09 September 2014; BMJ 349 doi:10.1136/bmj.g5205
- Clinical Review Published: 06 July 2016; BMJ 354 doi:10.1136/bmj.i2123
See more
- Individual care plans reduce falls and broken hips in New Zealand hospitalsBMJ December 05, 2016, 355 i6490; DOI: https://doi.org/10.1136/bmj.i6490
- One in three with mild cognitive impairment has depression, review findsBMJ November 28, 2016, 355 i6387; DOI: https://doi.org/10.1136/bmj.i6387
- Clinical commissioning groups will be rated on sepsis careBMJ November 25, 2016, 355 i6361; DOI: https://doi.org/10.1136/bmj.i6361
- GPs award potential £700m contract to Virgin CareBMJ November 14, 2016, 355 i6130; DOI: https://doi.org/10.1136/bmj.i6130
- Manufacturers tell FDA why they should be able to promote drugs and devices off labelBMJ November 14, 2016, 355 i6098; DOI: https://doi.org/10.1136/bmj.i6098
Cited by...
- Co-Occurring Obsessive-Compulsive Disorder and Panic Disorder: A Review of Their Etiology and Treatment
- Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study
- Cognitive decline associated with anticholinergics, benzodiazepines, and Z-drugs: findings from The Irish Longitudinal Study on Ageing (TILDA)
- Implementing a hybrid cognitive-behavioural therapy for pain-related insomnia in primary care: lessons learnt from a mixed-methods feasibility study
- Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trial
- Association between prescription of hypnotics/anxiolytics and mortality in multimorbid and non-multimorbid patients: a longitudinal cohort study in primary care
- Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis
- Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study
- Optimizing medications in older adults with cognitive impairment: Considerations for primary care clinicians
- Optimisation de la pharmacotherapie chez les personnes agees qui presentent un deficit cognitif: Facteurs dont les cliniciens de premiere ligne doivent tenir compte
- Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study
- Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents
- Advances in the management of chronic insomnia
- Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care
- Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol
- Benzodiazepine use and risk of Alzheimer's disease: case-control study
- Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care
- Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study
- Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline
- Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementia
- Research paper does not show causal link between benzodiazepine use and diagnosis of dementia
- Authors' reply to Coyle-Gilchrist and colleagues and Bocti and colleagues
- New Benzodiazepine Use Is Associated with Risk for Dementia